Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23726576)

1.

Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy.

Kim HG, Kim EY, Yu YJ, Kim GH, Jeong JW, Byeon JH, Chung BH, Yang CW.

Transplant Proc. 2013 May;45(4):1374-8. doi: 10.1016/j.transproceed.2013.01.088.

PMID:
23726576
2.

Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients.

Park KS, Yang WS, Han DJ, Park JB, Park JS, Park SK.

Clin Nephrol. 2012 Oct;78(4):303-11. doi: 10.5414/CN107617.

PMID:
22541690
3.

Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.

Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK.

Hepatology. 2002 Nov;36(5):1246-52.

PMID:
12395336
4.

Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States.

Reddy PN, Sampaio MS, Kuo HT, Martin P, Bunnapradist S.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1481-7. doi: 10.2215/CJN.09201010. Epub 2011 May 12.

5.

Long-term outcome of Hepatitis B-positive renal allograft recipients after development of antiviral treatment.

Park KS, Han DJ, Park JB, Park JS, Park S.

Clin Nephrol. 2012 Nov;78(5):391-8. doi: 10.5414/CN107565.

PMID:
22541689
6.

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

Long M, Jia W, Li S, Jin L, Wu J, Rao N, Feng H, Chen K, Deng H, Liu F, Su F, Song E.

Breast Cancer Res Treat. 2011 Jun;127(3):705-12. doi: 10.1007/s10549-011-1455-9. Epub 2011 Mar 29.

PMID:
21445574
7.
8.

Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?

Yen TH, Huang CC, Lin HH, Huang JY, Tian YC, Yang CW, Wu MS, Fang JT, Yu CC, Chiang YJ, Chu SH.

Nephrol Dial Transplant. 2006 Apr;21(4):1046-52. Epub 2006 Jan 3.

9.

Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.

Han DJ, Kim TH, Park SK, Lee SK, Kim SB, Yang WS, Park JS, Jung JG, Yu ES, Kim SC.

Transplantation. 2001 Feb 15;71(3):387-94.

PMID:
11233898
10.

Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.

Lee WC, Wu MJ, Cheng CH, Chen CH, Shu KH, Lian JD.

Am J Kidney Dis. 2001 Nov;38(5):1074-81.

PMID:
11684562
11.

The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.

Chen XQ, Peng JW, Lin GN, Li M, Xia ZJ.

Med Oncol. 2012 Jun;29(2):1237-41. doi: 10.1007/s12032-011-9974-0. Epub 2011 May 10.

PMID:
21556931
12.

[The antiviral treatment impacts on clinical outcomes of renal transplantation recipients with hepatitis B virus infection].

Wei ZW, Xu QH, Shu X, Jie YS, Zhang K, Xie QF, Li G.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Jun;23(3):224-6. Chinese.

PMID:
20104785
13.

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.

Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, Zhang X, Shen J, Wu M, Yan Y.

J Gastroenterol Hepatol. 2012 Jan;27(1):158-64. doi: 10.1111/j.1440-1746.2011.06888.x.

PMID:
21871026
14.

Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.

Ahn HJ, Kim MS, Kim YS, Kim SI, Huh KH, Ju MK, Ahn SH, Han KH.

J Med Virol. 2007 Nov;79(11):1655-63.

PMID:
17854044
15.

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.

Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

PMID:
21719446
16.

Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.

Yeo W, Hui EP, Chan AT, Ho WM, Lam KC, Chan PK, Mok TS, Lee JJ, Mo FK, Johnson PJ.

Am J Clin Oncol. 2005 Aug;28(4):379-84.

PMID:
16062080
17.

Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.

Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC.

Ann Surg. 2013 Mar;257(3):490-505. doi: 10.1097/SLA.0b013e318262b218.

PMID:
22868358
18.

An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.

Wu XY, Li X, Chen ZH, Wen JY, Lin Q, Xing YF, Dong M, Wei L, Wang TT, Chen J, Lin ZX, Wan XB, Ruan DY, Ma XK.

Tumour Biol. 2013 Apr;34(2):909-18. doi: 10.1007/s13277-012-0626-6. Epub 2012 Dec 27.

PMID:
23269606
19.

Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.

Murakami R, Amada N, Sato T, Orii T, Kikuchi H, Haga I, Ohashi Y, Okazaki H.

Clin Transplant. 2006 May-Jun;20(3):351-8.

PMID:
16824154
20.

Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.

Lau GK, Liang R, Wu PC, Lee CK, Lim WL, Au WY.

J Hepatol. 1998 Mar;28(3):359-68.

PMID:
9551671
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk